Related Experiment Videos
p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas
X Matias-Guiu1, M Cuatrecasas, E Musulen
1Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain.
Journal of Clinical Pathology
|April 1, 1994
Summary
The p53 tumor suppressor gene was studied in anaplastic carcinomas originating from thyroid papillary carcinomas. Results suggest p53 may promote tumor progression in these thyroid cancers.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Anaplastic carcinomas are aggressive thyroid cancers.
- Papillary carcinomas are well-differentiated thyroid cancers.
- The role of p53 in thyroid cancer progression is not fully understood.
Purpose of the Study:
- To investigate the expression of the p53 tumor suppressor gene.
- To determine the association between p53 expression and anaplastic carcinomas arising from papillary carcinomas.
Main Methods:
- Immunohistochemistry was used to detect p53 expression.
- Formalin-fixed, paraffin-embedded tissue samples from four cases were analyzed.
- Two distinct p53 monoclonal antibodies were employed.
Main Results:
- Nuclear immunostaining for p53 was observed in the anaplastic component in two out of four cases.
- The papillary carcinoma component consistently showed negative results for p53 immunostaining across all cases.
- Differential p53 expression was noted between the papillary and anaplastic components.
Conclusions:
- The findings support the hypothesis that p53 plays a role in promoting tumor progression.
- p53 may be involved in the transformation of papillary thyroid carcinoma to anaplastic carcinoma.
- Further research is warranted to elucidate the precise mechanisms of p53 in thyroid tumorigenesis.